stable gastric pentadecapeptide bpc 157 The Pleiotropic Beneficial Activity and Its Possible Relations with Neurotransmitter Activity bpc 157 stomach pain Acute

A Dose-Response Study

Mar 16 2020;10(1):4746

BPC-157's Category 2 FDA classification prohibits its use in compounded medications under Sections 503A and 503B

the FDA has stated it lacks sufficient information to know whether the substance would cause harm when administered to humans Evidence snapshot: The evidence base is almost entirely preclinical, decades of animal (largely rat) studies, mostly from one Croatian research group (Sikiric et al., University of Zagreb), with a single small human trial under the brand name "Bepecin" (around 2015) that did not lead to any FDA-approved use

Is BPC-157 an approved medicine or research substance

16 The possibility of these and additional systemic effects warrants large-scale clinical trials to determine a safe and effective dose